Home > Drug Search >
  • Targets: Monoamine oxidase A (MAO-A)
  •   > 
Drug Filter
Category:
chemistry (37) biology (4)
Status:
Approved (6) Withdrawn (1) Phase Ⅲ (8) Phase Ⅱ (18) Phase Ⅰ (8)
Clinical Stage:
Pending (3) Active (11) Discontinued (20)
Bio-Type:
Blood extraction (1) Fab fragment (1)
Company:
Daiichi Sankyo (1) GlaxoSmithKline (1) Lilly (1) Novartis (5) Ono Pharmaceutical (1) Pfizer (4) Sanofi (4) Shire (2) Takeda (1) Teva (1) Theravance Biopharma (2) UBE (1) Zambon (1) Max Delbrück Center for Molecular Medicine (1) Unknown (2) REGiMMUNE (1) Avraham Pharmaceutical (1) Krenitsky Pharmaceutical (2) Debiopharm Group (1) Pharmaleads (1) Inspiration Biopharmaceuticals (1) MicuRx (1) CeNeRx (1) LegoChemBio (1) Baxalta (2) Emory University (1) CSL Behring (1) Abbott (2) Abbvie (2) Bioprojet (3) Boehringer Ingelheim (1) Bristol-Myers Squibb (2)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (1) Alzheimer's disease (AD) (1) Angina pectoris (1) Anxiety (1) Cancer related pain (1) Cognitive disorders (1) Dementia (1) Depression (7) Diabetic nephropathy (1) Diarrhea (1) Female sexual dysfunction (1) Heart failure (11) Hypertension (14) Major depressive disorder (MDD) (1) Myocardial infarction (MI) (1) Kidney disorders (1) Pulmonary arterial hypertension (1) Small cell lung cancer (SCLC) (1) Smoking cessation (1) Venous thromboembolism (VTE) (1) Nosocomial Pneumonia (NP) (1) Chronic kidney disease (1) Pain (1) Diagnostic agents (1) Hemophilia A (1) Gram-positive bacterial infection (2) Brain injury (1) Graft versus host disease (1) Bleeding (1) Gastrointestinal disorders (1) Complicated skin and soft tissue infections (1) Von Willebrand disease (1) Renal failure (1) Cardiovascular disorders (2)
Country:
Aprv. Year:
1995 (1) 1996 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top